Opportunity
Ticagrelor Tablets
Response due
September 9, 2026
- Agency
- Nac Pharmaceuticals (36E797)
- Estimated value
- Not stated
Key dates
- Posted
- August 26, 2026
- Response due
- September 9, 2026
Who is this buyer
Organization
Buying history
- Records32 total
- Opportunities / awards3 / 8
- Value range$1,579,702 – $436,529,696
- ActiveJune 10, 2026 – October 26, 2026
What they buy
- Clinical (32)
Set-asides used
- No Set aside used (1)
Who holds their work today
- GOLDEN STATE MEDICAL SUPPLY, INC.2 wins · $37,369,721 · last September 8, 2026
- AVKARE LLC2 wins · $3,511,954 · last October 23, 2026
Also open from this buyer
- Sacubitril/Valsartan Tablets (VA-27-00014055)Due November 3, 2026 · Clinical
- Imatinib TabletsDue October 30, 2026 · Clinical
- Tacrolimus CapsulesClinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 325412
- PSC
- 6505